Carlyle-owned Life Sciences Firm Abingworth Names Joy Gosh as Managing Director

Abingworth, the Carlyle-owned international life sciences investment group with approximately $2bn under management, has recently appointed Joy Ghosh, PhD as managing director.

Ghosh will be based in Boston and work with the team to identify new investment opportunities and support existing investments in private and public companies, including those focused on clinical co-development.

Ghosh has over 15 years’ experience in life science investing and portfolio management, and in corporate strategy and drug development.

Gosh previously worked at Eventide Asset Management as a portfolio manager responsible for a portfolio of innovation-focused public and private healthcare and life science companies.

Prior to Eventide, Ghosh was vice president at Bain Capital. He has completed 24 private investments during his time at both firms and was on the board of multiple companies.

Earlier in his career, Ghosh held senior roles in business development and corporate strategy at Biogen, and as a project team leader at Novartis Institutes for BioMedical Research (NIBR).